Lung transplantation. Hypothermic storage for 24 hours in a colloid hyperosmolar solution

Area of Science:

• Transplantation immunology
• Organ preservation
• Veterinary surgery

Background:

• Lung transplantation is a complex procedure with challenges in organ preservation.
• Current preservation solutions have limitations in extending lung viability for transplantation.
• Hypothermic storage is critical for maintaining lung allograft quality.

Purpose of the Study:

• To evaluate the efficacy of a colloid hyperosmolar solution, modified silica gel function (MSGF), for lung allograft preservation.
• To compare the outcomes of lung transplantation using allografts preserved in MSGF versus Ringer's lactate.
• To determine the optimal duration for MSGF preservation of lung allografts.

Main Methods:

• Canine lung allografts were preserved using Ringer's lactate (3 hours) and MSGF (8, 16, 24 hours) at 4-7°C.
• Allografts were transplanted into recipient dogs, and survival rates were monitored.
• Arterial blood gas measurements and chest roentgenograms were used to assess graft condition.

Main Results:

• Lungs preserved in Ringer's lactate for 3 hours showed significant damage and poor recipient survival.
• MSGF preservation for up to 24 hours resulted in significantly improved recipient survival compared to Ringer's lactate.
• No significant differences in graft condition were observed between fresh and MSGF-preserved lungs.
• Pneumonia and rejection were the primary causes of death in both groups.

Conclusions:

• Modified silica gel function (MSGF) is an effective colloid hyperosmolar solution for 24-hour hypothermic storage of lung allografts.
• MSGF offers a viable alternative to traditional preservation methods, enhancing lung allograft viability for transplantation.
• Further research into MSGF may improve long-term outcomes in lung transplantation.